Health Care & Life Sciences » Pharmaceuticals | Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
132,170
148,189
154,708
140,809
142,028
Cost of Goods Sold (COGS) incl. D&A
59,704
66,732
67,436
67,278
70,839
Gross Income
72,466
81,457
87,272
73,531
71,189
SG&A Expense
48,347
55,579
58,466
60,653
60,007
EBIT
24,119
25,878
28,806
12,878
11,182
Unusual Expense
912
509
61
28
53
Non Operating Income/Expense
1,590
2,630
1,726
1,530
3,116
Interest Expense
1,274
1,092
4,959
634
788
Pretax Income
26,432
27,968
26,911
14,304
13,997
Income Tax
5,094
5,984
7,127
2,614
4,535
Equity in Affiliates
174
195
229
349
344
Consolidated Net Income
21,512
22,179
20,013
12,039
9,806
Net Income
21,515
22,179
20,013
12,039
9,806
Net Income After Extraordinaries
21,515
22,179
20,013
12,039
9,806
Net Income Available to Common
21,515
22,179
20,013
12,039
9,806
EPS (Basic)
126.52
130.22
117.35
72.24
59.13
Basic Shares Outstanding
170
170
171
167
166
EPS (Diluted)
126.04
129.75
116.99
72.09
59.01
Diluted Shares Outstanding
171
171
171
167
166
EBITDA
31,225
33,978
39,056
24,155
22,892
Non-Operating Interest Income
1,085
1,061
1,399
558
540
Minority Interest Expense
3
-
-
-
-

About Dr. Reddy's Laboratories

View Profile
Address
Door No. 8-2-337
Hyderabad TS 500034
India
Employees -
Website http://www.drreddys.com
Updated 09/14/2018
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others.